Walgreens Specialty Pharmacy highlights holistic support to boost oncology medication adherence

Advances in oncology are moving care out of the clinic and into patients' homes, with treatments becoming more personalized. This shift means patients often manage complex drug schedules themselves.

The new model creates challenges, as individuals must coordinate cancer therapy with other health conditions such as diabetes or hypertension, and cope with side-effect management without direct supervision.

Walgreens Specialty Pharmacy says it is addressing these issues by offering integrated support that looks beyond the cancer diagnosis. The program aims to help patients overcome clinical, financial and daily life obstacles that can interrupt therapy.

The company reports a medication adherence rate of 92%, well above the roughly 80% rate seen across the industry, suggesting its whole-patient approach may improve treatment continuity.